These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
280 related items for PubMed ID: 17000001
1. An apparent paradox: chemokine receptor agonists can be used for anti-inflammatory therapy. Ali S, O'Boyle G, Mellor P, Kirby JA. Mol Immunol; 2007 Mar; 44(7):1477-82. PubMed ID: 17000001 [Abstract] [Full Text] [Related]
2. Anti-inflammatory drug development: Broad or specific chemokine receptor antagonists? Russo RC, Garcia CC, Teixeira MM. Curr Opin Drug Discov Devel; 2010 Jul; 13(4):414-27. PubMed ID: 20597027 [Abstract] [Full Text] [Related]
3. [Chemokines a hope of specific anti-inflammatory treatment]. Schedvins P, Hjelmström P. Lakartidningen; 2002 Mar 07; 99(10):1056-9. PubMed ID: 12024779 [Abstract] [Full Text] [Related]
4. Chemokine sequestration by atypical chemokine receptors. Hansell CA, Simpson CV, Nibbs RJ. Biochem Soc Trans; 2006 Dec 07; 34(Pt 6):1009-13. PubMed ID: 17073739 [Abstract] [Full Text] [Related]
5. Relationships between glycosaminoglycan and receptor binding sites in chemokines-the CXCL12 example. Laguri C, Arenzana-Seisdedos F, Lortat-Jacob H. Carbohydr Res; 2008 Aug 11; 343(12):2018-23. PubMed ID: 18334249 [Abstract] [Full Text] [Related]
6. Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease. Donnelly LE, Barnes PJ. Trends Pharmacol Sci; 2006 Oct 11; 27(10):546-53. PubMed ID: 16911834 [Abstract] [Full Text] [Related]
7. Interfering with chemokine networks--the hope for new therapeutics. Schwarz MK, Wells TN. Curr Opin Chem Biol; 1999 Aug 11; 3(4):407-17. PubMed ID: 10419853 [Abstract] [Full Text] [Related]
8. Chemokine-receptor interactions: GPCRs, glycosaminoglycans and viral chemokine binding proteins. Lau EK, Allen S, Hsu AR, Handel TM. Adv Protein Chem; 2004 Aug 11; 68():351-91. PubMed ID: 15500866 [Abstract] [Full Text] [Related]
9. [Chemokines, a new family of cytokines in inflammatory cell recruitment]. Martínez Martínez CM, Hernández Pando R. Rev Invest Clin; 1999 Aug 11; 51(4):255-68. PubMed ID: 10546507 [Abstract] [Full Text] [Related]
10. The chemokine family. Potential therapeutic targets from allergy to HIV infection. Proudfoot AE. Eur J Dermatol; 1998 Aug 11; 8(3):147-57. PubMed ID: 9649701 [Abstract] [Full Text] [Related]
11. Anti-chemokine small molecule drugs: a promising future? Proudfoot AE, Power CA, Schwarz MK. Expert Opin Investig Drugs; 2010 Mar 11; 19(3):345-55. PubMed ID: 20113217 [Abstract] [Full Text] [Related]
12. Chemokines in transplantation: what can atypical receptors teach us about anti-inflammatory therapy? O'Boyle G, Ali S, Kirby JA. Transplant Rev (Orlando); 2011 Oct 11; 25(4):136-44. PubMed ID: 21514134 [Abstract] [Full Text] [Related]
13. Chemokines and their receptors: orchestrating a fine balance between health and disease. Sharma M. Crit Rev Biotechnol; 2010 Mar 11; 30(1):1-22. PubMed ID: 19780653 [Abstract] [Full Text] [Related]
14. Post-translational control of chemokines: a role for decoy receptors? Comerford I, Nibbs RJ. Immunol Lett; 2005 Jan 31; 96(2):163-74. PubMed ID: 15585320 [Abstract] [Full Text] [Related]
15. Targeting the chemokine network in renal inflammation. Eis V, Vielhauer V, Anders HJ. Arch Immunol Ther Exp (Warsz); 2004 Jan 31; 52(3):164-72. PubMed ID: 15247883 [Abstract] [Full Text] [Related]
16. Therapeutic inhibition of leukocyte recruitment in inflammatory diseases. Szekanecz Z, Koch AE. Curr Opin Pharmacol; 2004 Aug 31; 4(4):423-8. PubMed ID: 15251139 [Abstract] [Full Text] [Related]
17. Agonistic and antagonistic activities of chemokines. Loetscher P, Clark-Lewis I. J Leukoc Biol; 2001 Jun 31; 69(6):881-4. PubMed ID: 11404371 [Abstract] [Full Text] [Related]
18. Unravelling the mechanisms underpinning chemokine receptor activation and blockade by small molecules: a fine line between agonism and antagonism? Wise E, Pease JE. Biochem Soc Trans; 2007 Aug 31; 35(Pt 4):755-9. PubMed ID: 17635141 [Abstract] [Full Text] [Related]
19. Professional and part-time chemokine decoys in the resolution of inflammation. Hansell C, Nibbs R. Sci STKE; 2007 May 01; 2007(384):pe18. PubMed ID: 17473307 [Abstract] [Full Text] [Related]
20. CXCR2--the receptor to hit? Reutershan J. Drug News Perspect; 2006 Dec 01; 19(10):615-23. PubMed ID: 17299604 [Abstract] [Full Text] [Related] Page: [Next] [New Search]